Adherence to liraglutide among individuals with overweight and obesity: Patient characteristics and clinical measures.
Amit GuyAbed N AzabIdit F LibertyZaid AfawiAli AlhoashlaMuhammad Abu-TailakhPublished in: Diabetes, obesity & metabolism (2024)
Only 15.1% of study participants exhibited high adherence to treatment (PDC ≥80%) after 6 months of follow-up. Further research is needed to explore approaches to enhance adherence to liraglutide, including strategies to educate and support patients in their efforts to achieve and maintain weight loss with the use of this drug.